How many specifications does Talatumumab have? How much does it cost?_ Kanghule

Talatuzumab is an innovative bispecific antibody drug that provides new hope for the treatment of extensive-stage small cell lung cancer (ES-SCLC). Currently, talatumumab is produced by Amgen, a world-renowned biopharmaceutical company, and has been approved for marketing by the U.S. Food and Drug Administration. This article will introduce in detail the specifications, price and safety of talatumumab.

Talatumumab is available in several strengths

currently has two different strengths to meet the treatment needs of different patients. These two specifications are 1mg and 10mg respectively, both exist in the form of lyophilized powder and need to be dissolved and diluted before use. Each strength is individually packaged in single-dose vials, allowing medical professionals to accurately dose based on a patient's specific condition.

1 mg strength

The 1 mg strength of Talatumumab is suitable for small-dose administration in the initial treatment phase to gradually increase patient tolerance and reduce the occurrence of adverse reactions. This vial contains 1 mg of talatumumab lyophilized powder and necessary excipients.

10mg specification

The 10mg specification of talatumumab is the standard dose during treatment and is used to maintain treatment and maximize the efficacy of the drug. Each vial contains 10 mg of talatumumab lyophilized powder, which also contains necessary excipients to ensure the stability and solubility of the drug.

How much does talatumumab cost in different specifications?

As a cutting-edge biological agent, the price of talatumumab is relatively high. According to the reference data in 2025, the price of talatumumab varies depending on the specifications. The following prices are for reference only. The actual price may change due to factors such as region, sales channels, and medical insurance policies.

1 mg price

The reference price of 1 mg talatumumab is US$6,102 per box, which reflects the cost of small-dose administration in the initial treatment phase and also takes into account factors such as drug development, production and quality control.

Price of 10mg specification

The reference price of 10mg talatumumab is US$28,129 per box. As the main drug specification used in the treatment process, its price is relatively high, but it also reflects the potential value of the drug in improving patient prognosis to a certain extent.

How safe is talatumumab?

While talatumumab provides therapeutic benefits, it also comes with certain safety risks. Therefore, it is necessary to strictly follow medical instructions during use and closely monitor the patient's reaction.

Main adverse reactions

The most common adverse reactions in talatumumab treatment include cytokine release syndrome (CRS) and neurotoxic reactions, such as immune effector cell-associated neurotoxic syndrome (ICANS). These reactions may manifest as fever, hypotension, fatigue, headache, disturbance of consciousness and other symptoms. In addition, patients may also experience adverse reactions such as cytopenias, infection, and hepatotoxicity. Therefore, when using talatumumab, medical professionals need to pay close attention to changes in the patient's condition and take appropriate preventive measures and treatments.

Monitoring and Management

Medical professionals need to conduct a comprehensive assessment of the patient before treatment, including hematology, liver and kidney function tests. During the treatment process, it is also necessary to regularly monitor various indicators of the patient and adjust the treatment plan in a timely manner based on the patient's response. For patients who experience serious adverse reactions, the drug should be discontinued promptly and corresponding supportive treatment should be given.